-
-
-
-
-
-
-
Truist Securities Reiterates Buy Rating on Rapport Therapeutics (RAPP)
-
-
-
-
-
-
-
Rapport Therapeutics (RAPP) PT Raised to $75 at BTIG
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Rapport Therapeutics (RAPP)
-
-
-
-
-
-
-
Rapport Therapeutics, Inc. (RAPP) Reports Q4 Loss of $0.72
-
-
-
-
-
-
-
Rapport Therapeutics (RAPP) PT Raised to $40 at H.C. Wainwright
-
-
-
-
-
-
-
Rapport Therapeutics terminates stock sales agreement prospectus
-
-
-
-
-
-
-
TD Cowen on Rapport Therapeutics (RAPP): 'KOL at Investor Dinner Strongly Optimistic for RAP-219'
-
483,110 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


